{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:16:27Z","timestamp":1789499787192,"version":"build-2803163510"},"reference-count":150,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["PI06\/0024"],"award-info":[{"award-number":["PI06\/0024"]}]},{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["PS09\/00748"],"award-info":[{"award-number":["PS09\/00748"]}]},{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["PI12\/00060"],"award-info":[{"award-number":["PI12\/00060"]}]},{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["PI15\/00525"],"award-info":[{"award-number":["PI15\/00525"]}]},{"name":"RETICS Programs","award":["RD12\/0009"],"award-info":[{"award-number":["RD12\/0009"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bprclinrheum.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.berh.2016.10.006","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T03:16:11Z","timestamp":1478747771000},"page":"851-869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Cardiovascular disease in inflammatory rheumatic diseases"],"prefix":"10.1016","volume":"30","author":[{"given":"Santos","family":"Casta\u00f1eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Nurmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2016.10.006_bib1","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/heartjnl-2015-307838","article-title":"Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders","volume":"102","author":"Agca","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.berh.2016.10.006_bib2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.semarthrit.2014.12.002","article-title":"CARMA Project Collaborative Group. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: baseline data of the CARMA Project","volume":"44","author":"Casta\u00f1eda","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib3","first-page":"813","article-title":"Trend in and predictors for cardiovascular mortality in patients with rheumatoid arthritis over a period of 15 years: a prospective cohort study","volume":"34","author":"Van den Hoek","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib4","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avi\u00f1a-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib5","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib6","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/ard.2010.143396","article-title":"The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study","volume":"70","author":"Lindhardsen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib7","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/ard.2008.094151","article-title":"Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation","volume":"68","author":"van Halm","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib8","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study","volume":"61","author":"Peters","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jbspin.2011.02.012","article-title":"Mortality in spondylarthritis","volume":"78","author":"Prati","year":"2011","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.berh.2016.10.006_bib11","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib12","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1002\/art.30581","article-title":"Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study","volume":"63","author":"Szabo","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/ard.2009.110593","article-title":"Ankylosing spondylitis: a risk factor for myocardial infarction?","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.semarthrit.2014.10.007","article-title":"Cardiovascular events in ankylosing spondylitis: an updated meta-analysis","volume":"44","author":"Mathieu","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib15","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/jdv.12024","article-title":"Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis","volume":"27","author":"Dauden","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.berh.2016.10.006_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/B:EJEP.0000020447.59150.f9","article-title":"Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients","volume":"19","author":"Mallbris","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.berh.2016.10.006_bib17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2796.2010.02310.x","article-title":"Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study","volume":"270","author":"Ahlehoff","year":"2011","journal-title":"J\u00a0Intern Med"},{"issue":"70","key":"10.1016\/j.berh.2016.10.006_bib19","first-page":"284","article-title":"Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis","volume":"1","author":"Jamnitski","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/acr.22536","article-title":"Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study","volume":"67","author":"Ernste","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2016.10.006_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrrheum.2012.16","article-title":"Validated methods for assessment of subclinical atherosclerosis in rheumatology","volume":"8","author":"Kerekes","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9343(03)00133-5","article-title":"HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis","volume":"114","author":"Gonzalez-Juanatey","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.berh.2016.10.006_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/ard.2003.007740","article-title":"Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity","volume":"63","author":"Vaudo","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3899\/jrheum.100668","article-title":"Assessment of subclinical vascular disease associated with ankylosing spondylitis","volume":"38","author":"Bodn\u00e1r","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.22530","article-title":"Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib26","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar3382","article-title":"Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with longstanding disease","volume":"13","author":"Gonz\u00e1lez-Juanatey","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2016.10.006_bib27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semarthrit.2008.01.012","article-title":"Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis","volume":"38","author":"Gonzalez-Juanatey","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.30265","article-title":"Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis","volume":"63","author":"Evans","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.semarthrit.2010.06.006","article-title":"Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis","volume":"40","author":"van Sijl","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib30","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1160\/TH14-11-0921","article-title":"Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies","volume":"113","author":"Ambrosino","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.berh.2016.10.006_bib31","first-page":"1219","article-title":"High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis","volume":"32","author":"Gonzalez-Gay","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib32","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/annrheumdis-2012-203101","article-title":"Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study","volume":"73","author":"Corrales","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib33","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1136\/annrheumdis-2013-203688","article-title":"Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than coronary artery calcification score to detect subclinical atherosclerosis in patients with rheumatoid arthritis","volume":"72","author":"Corrales","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/ard.2007.073718","article-title":"Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis","volume":"67","author":"Gerli","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3899\/jrheum.090667","article-title":"Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis","volume":"37","author":"Peters","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MD.0b013e3181c10773","article-title":"The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease","volume":"88","author":"Gonzalez-Juanatey","year":"2009","journal-title":"Med (Baltimore)"},{"key":"10.1016\/j.berh.2016.10.006_bib37","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.22884","article-title":"High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/ATVBAHA.110.214585","article-title":"Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-\u03b1 blockers and traditional disease-modifying antirheumatic drugs","volume":"31","author":"Di Minno","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.berh.2016.10.006_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/rheumatology\/kes243","article-title":"Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis","volume":"52","author":"Liao","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.10.006_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rdc.2013.10.005","article-title":"Cardiovascular disease in rheumatoid arthritis","volume":"40","author":"Sen","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.berh.2016.10.006_bib41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.berh.2015.09.003","article-title":"Cardiovascular disease in rheumatoid arthritis: current perspectives on assessing and mitigating risk in clinical practice","volume":"29","author":"Giles","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib42","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/rheumatology\/ker258","article-title":"Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis","volume":"50","author":"Bergstrom","year":"2011","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.10.006_bib43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.autrev.2009.02.015","article-title":"Cardiovascular risk in rheumatoid arthritis","volume":"8","author":"Nurmohamed","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2016.10.006_bib44","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1136\/ard.2009.125476","article-title":"Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis","volume":"69","author":"Solomon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","article-title":"Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review","volume":"72","author":"Jamnitski","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib46","doi-asserted-by":"crossref","first-page":"e78151","DOI":"10.1371\/journal.pone.0078151","article-title":"The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2016.10.006_bib47","first-page":"10928","article-title":"Metabolic syndrome in rheumatoid arthritis","volume":"7","author":"Ferraz-Amaro","year":"2013","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.berh.2016.10.006_bib48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.2009.05287.x","article-title":"Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-alpha therapy","volume":"1193","author":"Gonzalez-Gay","year":"2010","journal-title":"Ann N. Y Acad Sci"},{"key":"10.1016\/j.berh.2016.10.006_bib49","first-page":"850","article-title":"TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients","volume":"30","author":"Miranda-Filloy","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib50","doi-asserted-by":"crossref","first-page":"e14328","DOI":"10.1371\/journal.pone.0014328","article-title":"Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases","volume":"5","author":"Schultz","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2016.10.006_bib51","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1097\/01.ASN.0000141966.69934.21","article-title":"The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity","volume":"15","author":"Wisse","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.berh.2016.10.006_bib52","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.berh.2016.10.006_bib53","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/art.23766","article-title":"Association of body fat with C-reactive protein in rheumatoid arthritis","volume":"58","author":"Giles","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib54","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1002\/art.20612","article-title":"Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis","volume":"50","author":"Maradit Kremers","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrrheum.2010.105","article-title":"Rheumatoid cachexia and cardiovascular disease","volume":"6","author":"Summers","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/acr.20363","article-title":"Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis","volume":"63","author":"Mok","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2016.10.006_bib57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","article-title":"Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis","volume":"36","author":"Kimhi","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib58","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/rheumatology\/kem169","article-title":"Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis","volume":"46","author":"Panoulas","year":"2007","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.10.006_bib59","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.semarthrit.2011.07.004","article-title":"Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis","volume":"41","author":"Chung","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jbspin.2010.07.016","article-title":"Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis","volume":"78","author":"Boyer","year":"2011","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.berh.2016.10.006_bib61","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/ken090","article-title":"Cardiovascular risk profile of patients with psoriatic arthritis compared to controls\u2013the role of inflammation","volume":"47","author":"Tam","year":"2008","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.10.006_bib62","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1136\/annrheumdis-2013-204933","article-title":"Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox","volume":"73","author":"Gonz\u00e1lez-Gay","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib63","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2009.122374","article-title":"Total cholesterol and LDL levels decrease before rheumatoid arthritis","volume":"69","author":"Myasoedova","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib64","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/art.24802","article-title":"Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis","volume":"60","author":"Charles-Schoeman","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib65","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/annrheumdis-2011-200493","article-title":"Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis","volume":"71","author":"Charles-Schoeman","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib66","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5","article-title":"Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile","volume":"44","author":"Hurt-Camejo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib67","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jbspin.2010.05.001","article-title":"Spondyloarthropathies: an independent cardiovascular risk factor?","volume":"77","author":"Mathieu","year":"2010","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.berh.2016.10.006_bib68","first-page":"612","article-title":"Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis","volume":"31","author":"Papagoras","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib69","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ejim.2012.06.016","article-title":"Inflammatory arthritis as a novel risk factor for cardiovascular disease","volume":"23","author":"John","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.berh.2016.10.006_bib70","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/ard.2005.050443","article-title":"Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis","volume":"65","author":"van Halm","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib71","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.24492","article-title":"Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis","volume":"60","author":"van Eijk","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib72","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.semarthrit.2011.04.003","article-title":"The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis","volume":"41","author":"van Sijl","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib73","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","article-title":"Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate","volume":"54","author":"Maini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semarthrit.2016.03.004","article-title":"Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist","volume":"46","author":"Charles-Schoeman","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib75","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/acr.20393","article-title":"Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients","volume":"63","author":"Morris","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2016.10.006_bib76","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrrheum.2016.103","article-title":"Spondyloarthropathies: CVD prevention and statin therapy in ankylosing spondylitis","volume":"12","author":"Semb","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib77","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/art.23650","article-title":"High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study","volume":"58","author":"Kremers","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib78","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","article-title":"Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis","volume":"46","author":"Young","year":"2007","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.10.006_bib79","first-page":"61","article-title":"Subclinical coronary artery calcification and relationship to disease duration in women with rheumatoid arthritis","volume":"35","author":"Kao","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib80","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3899\/jrheum.090188","article-title":"Autoantibodies and the risk of cardiovascular events","volume":"36","author":"Liang","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib81","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/art.10419","article-title":"Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients","volume":"46","author":"Goodson","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib82","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/art.38071","article-title":"Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis","volume":"65","author":"Crowson","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib83","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/art.21204","article-title":"Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year follow-up study of a primary care-based inception cohort","volume":"52","author":"Goodson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib84","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.amjcard.2007.11.076","article-title":"Cardiovascular outcomes in male veterans with rheumatoid arthritis","volume":"101","author":"Banerjee","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.berh.2016.10.006_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.22482","article-title":"HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis","volume":"57","author":"Gonzalez-Gay","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib86","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semarthrit.2008.06.001","article-title":"Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease","volume":"39","author":"Gonzalez-Gay","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib87","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/rheumatology\/keq388","article-title":"Uric acid and cardiovascular risk in rheumatoid arthritis","volume":"50","author":"Daoussis","year":"2011","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.10.006_bib88","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/rheumatology\/kem159","article-title":"Association of serum uric acid with cardiovascular disease in rheumatoid arthritis","volume":"46","author":"Panoulas","year":"2007","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.10.006_bib89","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.berh.2016.10.006_bib90","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/annrheumdis-2012-203137","article-title":"Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study","volume":"73","author":"Lindhardsen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib91","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/rheumatology\/kes353","article-title":"Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study","volume":"52","author":"Avi\u00f1a-Zubieta","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.10.006_bib92","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/ard.2010.140210","article-title":"Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study","volume":"70","author":"Avi\u00f1a-Zubieta","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib93","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/art.22418","article-title":"Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study","volume":"56","author":"Davis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib94","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2016.10.006_bib95","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/acr.20371","article-title":"Systematic review and meta-analysis: anti-tumor necrosis factor \u03b1 therapy and cardiovascular events in rheumatoid arthritis","volume":"63","author":"Barnabe","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2016.10.006_bib96","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.autrev.2016.07.026","article-title":"Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers","volume":"15","author":"L\u00f3pez-Mej\u00edas","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2016.10.006_bib97","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.23149","article-title":"Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis","volume":"58","author":"Farragher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib98","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semarthrit.2008.01.019","article-title":"Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis","volume":"38","author":"Rojas-Villarraga","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib99","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2010.10.052","article-title":"TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"216","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.berh.2016.10.006_bib100","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/ar2989","article-title":"A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis","volume":"12","author":"Palomino-Morales","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2016.10.006_bib101","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.atherosclerosis.2015.12.011","article-title":"Vitamin D receptor GATG haplotype association with atherosclerotic disease in patients with rheumatoid arthritis","volume":"245","author":"L\u00f3pez-Mej\u00edas","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.berh.2016.10.006_bib102","doi-asserted-by":"crossref","first-page":"R146","DOI":"10.1186\/ar4608","article-title":"Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis","volume":"16","author":"Garc\u00eda-Berm\u00fadez","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2016.10.006_bib103","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.atherosclerosis.2012.06.008","article-title":"NFKB1-94ATTG ins\/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis","volume":"224","author":"L\u00f3pez-Mej\u00edas","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.berh.2016.10.006_bib104","doi-asserted-by":"crossref","first-page":"31979","DOI":"10.1038\/srep31979","article-title":"Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis","volume":"6","author":"L\u00f3pez-Mej\u00edas","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2016.10.006_bib105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.berh.2016.10.006_bib106","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.berh.2016.10.006_bib107","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.berh.2016.10.006_bib108","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib109","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2362.2010.02333.x","article-title":"Risk factors and early detection of atherosclerosis in rheumatoid arthritis","volume":"40","author":"de Groot","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.berh.2016.10.006_bib110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrrheum.2011.168","article-title":"Cardiovascular safety of biologic therapies for the treatment of RA","volume":"8","author":"Greenberg","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib111","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","article-title":"Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.10.006_bib112","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1161\/01.CIR.99.16.2079","article-title":"Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events","volume":"99","author":"Biasucci","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.10.006_bib113","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.10.006_bib114","doi-asserted-by":"crossref","first-page":"785946","DOI":"10.1155\/2012\/785946","article-title":"Atherogenic index and high-density lipoproteincholesterol as cardiovascular risk determinants in rheumatoid arthritis: theimpact of therapy with biologicals","volume":"2012","author":"Popa","year":"2012","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.berh.2016.10.006_bib115","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/rheumatology\/keu224","article-title":"Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment","volume":"53","author":"Choy","year":"2014","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.10.006_bib116","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/art.33336","article-title":"Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor \u03b1-induced VE-cadherin cleavage","volume":"64","author":"Sidib\u00e9","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib117","doi-asserted-by":"crossref","first-page":"480784","DOI":"10.1155\/2012\/480784","article-title":"A\u00a0systematic literature review the association of lipoprotein(a) and autoimmune diseases and atherosclerosis","volume":"2012","author":"Missala","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib118","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2013.09.006","article-title":"Cardiovascular risk in rheumatoid arthritis: how to lower the risk?","volume":"231","author":"van Breukelen-van der Stoep","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.berh.2016.10.006_bib119","first-page":"937","article-title":"Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis","volume":"34","author":"Aubry","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib120","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3899\/jrheum.120621","article-title":"Carotid plaque characteristics and disease activity in rheumatoid arthritis","volume":"40","author":"Semb","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib121","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/rheumatology\/kes242","article-title":"Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management","volume":"52","author":"Russolillo","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.10.006_bib122","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1002\/art.21349","article-title":"How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?","volume":"52","author":"Crowson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2014.01.002","article-title":"Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion","volume":"44","author":"Mart\u00edn-Mart\u00ednez","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib124","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2016-310111","article-title":"Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care","author":"Emanuel","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.berh.2016.10.006_bib125","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2016-310292","article-title":"Cardiovascular risk factor assessment: still an unmet need in chronic inflammatory diseases","author":"Gonz\u00e1lez-Gay","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.berh.2016.10.006_bib126","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib127","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","author":"Agca","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib128","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jbspin.2014.01.009","article-title":"Cardiovascular risk in rheumatoid arthritis","volume":"81","author":"Soubrier","year":"2014","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.berh.2016.10.006_bib129","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00296-014-3196-7","article-title":"Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis","volume":"35","author":"Loza","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2016.10.006_bib130","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/rheumatology\/ken159","article-title":"Hypertension in rheumatoid arthritis","volume":"47","author":"Panoulas","year":"2008","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.10.006_bib131","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/ard.2010.141523","article-title":"Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study","volume":"70","author":"Provan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib132","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.berh.2016.10.006_bib133","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ahj.2013.03.018","article-title":"Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis","volume":"166","author":"Everett","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.berh.2016.10.006_bib134","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/ard.2010.129916","article-title":"Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis","volume":"70","author":"Greenberg","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/art.30654","article-title":"Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis","volume":"64","author":"Ljung","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.006_bib136","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1186\/ar4271","article-title":"SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis","volume":"15","author":"G\u00f3mez-Vaquero","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2016.10.006_bib137","first-page":"885","article-title":"Carotid ultrasound in the cardiovascular risk stratification of patients with ankylosing spondylitis: results of a population-based study","volume":"34","author":"Rueda-Gotor","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib138","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/1759720X15591801","article-title":"Atherosclerosis in psoriatic disease: latest evidence and clinical implications","volume":"7","author":"Eder","year":"2015","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib139","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/hrt.2007.134890","article-title":"Performance Of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study","volume":"94","author":"Hippisley-Cox","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.berh.2016.10.006_bib140","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/art.39195","article-title":"Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib141","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13075-015-0576-7","article-title":"Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study","volume":"17","author":"Corrales","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2016.10.006_bib142","first-page":"A5104","article-title":"Summary of the multidisciplinary guideline on cardiovascular risk management (revision 2011)","volume":"156","author":"Wiersma","year":"2012","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.berh.2016.10.006_bib143","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/annrheumdis-2011-201209","article-title":"Carotid ultrasound in the cardiovascular risk stratification of patients with rheumatoid arthritis: when and for whom?","volume":"71","author":"Gonz\u00e1lez-Gay","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib144","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2016.10.006_bib145","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/keq295","article-title":"Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial","volume":"50","author":"Semb","year":"2011","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.berh.2016.10.006_bib146","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.berh.2016.10.006_bib147","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/ard.2009.115717","article-title":"Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?","volume":"69","author":"Toms","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib148","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3899\/jrheum.121302","article-title":"Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study","volume":"40","author":"Akkara Veetil","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.10.006_bib149","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/ard.2010.142455","article-title":"Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study","volume":"70","author":"De Vera","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.006_bib150","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694216300791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694216300791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T13:39:04Z","timestamp":1718890744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694216300791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":150,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1521694216300791"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2016.10.006","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disease in inflammatory rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2016.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}